Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Recruiting · NCT06650501 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia | S. Aureus Bacteremia; S. Aureus Bloodstream Infection; Staphylococcus Aureus Bacteremia; Staphylococcus Aureus Bloodstream Infection; Staphylococcus Aureus Endocarditis; Staphylococcus Aureus Septicemia | Recruiting | Phase 4 | 2026-09-24 | NCT06650501 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 139 |
| University of Melbourne | 71 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital) | Montreal | Canada | 3 |
| NL and Labrador Health Services- Health Sciences Centre | St. John's | Canada | 1 |
| NL and Labrador Health Services- St. Clare's Mercy Hospital | St. John's | Canada | 2 |